DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Vusion is a drug marketed by Mylan and is included in one NDA. There is one patent protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in VUSION is miconazole nitrate; petrolatum, white; zinc oxide. There are twenty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the miconazole nitrate; petrolatum, white; zinc oxide profile page.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be March 30, 2028. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
Generic Entry Opportunity Date for VUSION
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for VUSION
Identify potential brand extensions & 505(b)(2) entrants
|Image Dermatology P.C.||Phase 0|
|Stiefel, a GSK Company||Phase 4|
Pharmacology for VUSION
|Drug Class||Azole Antifungal |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Mylan||VUSION||miconazole nitrate; petrolatum, white; zinc oxide||OINTMENT;TOPICAL||021026-001||Feb 16, 2006||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Mylan||VUSION||miconazole nitrate; petrolatum, white; zinc oxide||OINTMENT;TOPICAL||021026-001||Feb 16, 2006||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|